BGM (BGM Group) Beta: 2.2583 (As of Jun. 24, 2026)


BGM BGM Group Ltd BGM
53 GF Score
Price $0.34
GF Value $1.24
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is BGM Group Beta?

BGM Group BGM -4.16% 53 Beta is 2.2583 as of Jun. 24, 2026. GuruFocus rates BGM with a GF Score™ of 53/100 and a GF Value™ of $1.24 (Possible Value Trap). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), BGM Group's Beta is 2.2583.


BGM Group  (NAS:BGM) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


BGM Group Beta Related Terms


BGM Group Beta Historical Data

* Premium members only.

The historical data trend for BGM Group's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BGM Group Beta Chart

BGM Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 1.65

BGM Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1.61 1.65 1.70

BGM vs INCR, SCYX, CTOR: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BGM Group's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BGM Group Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BGM Group's Beta distribution charts can be found below:

* The bar in red indicates where BGM Group's Beta falls into.


BGM
53GF Score
BGM Group Ltd BGM
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BGM Group Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.2583 mean?
BGM Group (BGM) has a Beta of 2.2583 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for BGM Group and its competitors.
Is BGM Group's Beta too high?
BGM Group's current Beta is 2.2583. Overall, BGM Group has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BGM Group's Beta compare to INCR and SCYX?
BGM Group's Beta of 2.2583 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for BGM Group and its competitors. BGM Group's current Beta is 2.2583. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BGM Group stock overvalued right now?
Based on GuruFocus' analysis, BGM Group (BGM) is currently considered Possible Value Trap. The stock's GF Value™ is $1.24, compared to a current price of $0.34 — trading 72.5% below its estimated fair value. The current Beta is 2.2583. BGM Group's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For BGM Group (BGM), the current Beta is 2.2583 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BGM Group (BGM) Overvalued in 2026?

Based on GuruFocus' analysis, BGM Group stock appears to be undervalued. The current stock price of $0.34 is trading 72.5% below its estimated GF Value™ of $1.24. GuruFocus considers BGM Group to be Possible Value Trap.

Key valuation signals for BGM:

  • Beta: 2.2583
  • GF Value™: $1.24 vs. price of $0.34 (72.5% below fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the BGM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BGM Group Business Description

Address No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
53GF Score

Get the complete analysis for BGM

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price
$1.24
GF Value